Your browser doesn't support javascript.
loading
CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway.
Yang, Shuang; Peng, Li Rong; Yu, Ai Qing; Li, Jiang.
Affiliation
  • Yang S; Department of Clinical Laboratory, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha 410005, PR China. Electronic address: 664166433@hunnu.edu.cn.
  • Peng LR; Department of Clinical Laboratory, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha 410005, PR China.
  • Yu AQ; Department of Clinical Laboratory, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha 410005, PR China.
  • Li J; Department of Clinical Laboratory, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), Changsha 410005, PR China.
Ann Hepatol ; 28(5): 101118, 2023.
Article in En | MEDLINE | ID: mdl-37268061
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Animals / Humans Language: En Journal: Ann Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Animals / Humans Language: En Journal: Ann Hepatol Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article